ArticleInflammopharmacology2022

Short-term celecoxib (celebrex) adjuvant therapy: a clinical trial study on COVID-19 patients.

Habib Ghaznavi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.